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ABSTRACT
Controlling gene regulation is an important aspect in the life of cells that provides
them the ability to carry out their functional roles within an organism. Unregulated or
misregulated gene expression can lead to cell immortalization or death. Chromatin
remodeling functions as a regulator for many important DNA functions including
transcription, the first step of gene expression in cells. The Chromodomain-HelicaseDNA binding domain gene family (CHD) is evolutionarily conserved and has distinct
structural motifs that indicate a role in chromatin remodeling and DNA repair. The CHD
proteins have both helicase activity, allowing the winding and unwinding of DNA, and an
effect on histone acetylation through their role of the Nucleosome Remodeling and
Histone Deacetylation (NuRD) complex. The NuRD complex participates in the
deacetylation of chromatin histones, in addition to orchestrating ATP-dependent
remodeling of the the chromatin structure.. Histones are, in their native state, positively
charged, interacting tightly with the negatively charged DNA that wraps around them.
Deacetylating previously acetylated histones returns them to this state and forces them
to have greater attraction to the DNA, causing low levels of transcription and gene
expression. Chd4 is the largest protein in the NuRD complex and can carry out many
functions of the complex on its own. We are using Chd4 knockout mice and cell lines to
look further into the function of the protein. Preliminary data shows that homozygous
null embryos are lethal, but the definite day of lethality has yet to be determined. In
addition, cell line experiments show that cells heterozygous for Chd4 grow faster than
wild type cells. Analysis of gene expression in mouse embryos shows gene expression

in brain precursors, dermal precursors, and the dorsal aorta. Future experiments will
address organismal cancer susceptibility and the transformation potential of cell lines.

CHROMATIN REMODELING
Though there are many
ways to regulate genes in the
nucleus of any given cell, one of
the most basic ways is through the
relative state of chromatin. Cells
use chromatin to store vast
amounts of DNA in a relatively
compact space through the
formation of a structu re that looks
like "beads on a string." The basic
unit of chromatin, the bead,
consists of 146 or 147 base pairs
of DNA wrapped tightly around an
octamer core that consists of two of Figure 1. Chromatin structure from the DNA strand to the
entire chromosome. From (1).

each of the following proteins: H2A, H2B, H3, and H4 (2,3). These proteins are all
highly positively charged, allowing for a strong interaction between them and the
negatively charged backbone of DNA. Many factors contribute to how tightly the
"beads" are wrapped; these differing levels of tightness are an important contributing
factor in determining the level of gene transcription. Additionally, nucleosomes are

folded into higher order structures, as shown in Figure 1 (3). One important factor in
this folding of histones into larger structures is the histone tail. These tails, usually on
the amino end of the protein protrude from the central octamer and are frequent targets
I

of modification (4). These modifications either disrupt or enhance the formation of
higher order structures, making them extremely important in chromatin maintenance
and gene expression.
There are two major classes of chromatin remodeling complexes: those whose
action on chromatin is dependent of the use of ATP to disturb histone-DNA interactions
and those which covalently modify the histone proteins themselves, resulting in
differential histone-DNA interaction (5). The ATP-dependent remodeling enzymes can
range from a single polypeptide to complexes greater than 1 MDa in mass (4). For
ease of reference, both the single peptides and the complexes will be referred to as
complexes. At the core of each complex is a helicase-like subunit that belongs to the
SWI2/SNF2 family of proteins. Based on the relative homologies of these subunits,
three major subfamilies have emerged: the SWI2/SNF2 family, the ISWI family, and the
Mi-2/CHD family (4,5). The SWI2/SNF2 family was first discovered in yeast using
genetic screens that identified switch and sucrose nonfermenting mutations. After
characterization, investigators discovered that both mutations affected the same
complex, one which had the ability to make nucleosomal DNA more easily accessible
dependent on the presence of ATP (6). The ATPase ISWI, first discovered in
Drosophila melanogaster, can remodel nucleosomes either by itself or in its full

complex. Further characterization of ISWI family members showed that they act by the
induction of nucleosome sliding to different DNA segments, effectively freeing up the

portion of DNA for access by various factors (6).

In addition to the ATPase domain, the

Mi-2/CHD family members all have chromodomains and a DNA-binding domain (5).
These family members show efficient nucelosome remodeling activity alone and in
complex (7). All three of these complexes have members represented in humans,
showing that while they might perform some sirTliiar functions, evolutionarily, they most
likely have some unique roles as well (4).
In addition to ATP-Dependent chromatin remodeling, chromatin is also regulated
through covalent modification of histones. One common method of chromatin
modification, and perhaps the most investigated, is acetylation. In this method, histone
acetyltransferase (HAT) and histone deacetlyase (HD) complexes either add or remove,
respectively, acetyl groups from the lysine residues on histone tails (5). These lysine
residues are positively charged. After acetylation by the HAT complexes, they lose this
positive charge. This causes a decrease in the electrostatic interactions between the
previously positively charged histones and the negatively charged DNA, allowing the
DNA to be more accessible to the binding of various transcription factors.
In addition to acetylation, histones are also modified by phosphorylation,
methylation, and ubiquitination (8). There is building evidence that the combination of
modifications on histone tails can lead to distinct downstream events with regard to
transcription or silencing of genes (9). Phosphorylation seems to be evident in both
transcriptional activation and chromosome condensation, activities that upon first glance
would seem to be dichotomous. Although there is not currently a conclusive
explanation, this data seems to point to the modifications altering the binding surface of
the histone as opposed to directly altering the chromatin (8). Methylation is involved in

both gene activation and suppression. Though this also seems counterintuitive, it is
possible because varying substrates allow for different outcomes. Upon arginine
methylation, for instance, genes seem to be activated, whereas upon lysine methylation,
they are silenced (8). Ubiquitination is important to both meiotic and mitotic growth, in
addition to possible roles in transcription. Though all of these upon first glance seem to
paint a rather blurry picture, the "histone-code" hypothesis attempts to include all of the
tail modifications in a unified theory. All of these modifications are on either specific
residues or at least on a subset of them, indicating perhaps that "every amino acid in
histone tails has specific meaning and is part of the vocabulary of the overall code" (9).
This theory points to the specific combination of modifications on a nucleosome
determining unique outcomes and downstream effects. It is only beginning to be
investigated and has vast irrlplications if it is proved to be correct.

Mi-2/NuRD COMPLEX
As discussed previously, the Mi-2/NuRD complex, also known as the NURD or
NRD, hereafter referred to as the NuRD complex for simplicity, is an ATP-Dependent
chromatin remodeling complex (10). In addition to the ATPase subunit CHD4, the
NuRD complex also contains the histone deacetylases HDAC1 and HDAC2, the histone
binding proteins RbAp46 and RbAp48, a methyl-CpG-binding domain-containing
protein, MBD3, and a member of the metastasis-associated protein family, possibly
leading to specialization of the complex (10,11). The proteins HDAC1, HDAC2,
RbAp46, and RbAp48 form a fundamental core that is shared between the Sin3/HDAC
complex and the NuRD complex. The Sin3 complex also contains 3 additional peptides

outside of the core, but, unlike the NuRD, does not show nucleosome remodeling
activity in addition to the histone deacetylase activity of the complex (11).
The largest component of the NuRD, CHD4, will be discussed in great detail in
the next section, but is a multi-domain protein with two PHD Zn-finger domains, two
chromodomains, the SWl2/SNF2-related ATPase domain, an additional helicase
domain, and other domains whose functions are as yet unknown (12). Another large
component of the NuRD is the histone deacetylases. These enzymes lead to the
deacetylation of previously acetylated histones, causing the histone-bound DNA to
become less accessible for transcription (13). HDAC1 and HDAC2 are homologous to
a great extent, sharing 84% identity. It is currently unclear whether they have unique
functions, but they seem to function similarly in the repression of transcription (14).
They have been implicated in both short and long term patterns of gene activity, usually
in a repressive capacity (15). There are two major HDAC1/2 complexes that have been
identified in human cell lines, cl and cll, with cll being similar to the NuRD (14).
HDAC1 and HDAC2 can each be found either alone or together in these complexes,
and can be dissociated from one another using a mild agent. This data led Humphrey
et al. to present a model through which these two histone deacetylases interact via
dimerization. This dimerization also led them to propose a method for targeting the
HDAC complexes. In this model, MBD2, which was found in the HDAC1 cll complex,
specifically binds to methylated DNA. HDAC2 might be colocalized with HDAC1 via this
dimerization to allow the complex to work to silence methylated DNA (14).
The RbAp46/48 proteins are histone chaperones that are involved in many
complexes associated with chromatin functions including the NuRD and Sin3

complexes as previously mentioned. Additionally, they are also found in Hat1, a histone
acetyl transferase; NURF, a Drosophila transcription factor; CAF-1, a factor key in the
assembly of chromatin; and PRC2, a histone methylating complex linked to
transcriptional repression. Generally, researchers view RbAp46/48 as centrally involved
in all of these complexes through their histone interactions, allowing the complexes to
be localized and have their respective effects on the histones (16).
Another protein found in the NuRD is MBD3, which contains a methyl-CpG
binding domain. In Xenopus, this MBD3 specifically binds to methylated DNA, but this
is not the case in mammalian cells (10,17). Upon examination, it appears that MBD3 is
not involved with the localization of mammalian NuRD to methylated DNA, but instead
acts as a mediator between MTA2 and the fundamental histone deacetylase core of the
NuRD (11). This is further substantiated by the fact that it seems to be inaccessible to
antibodies while in the NuRD complex. Additionally, there are two forms of MBD3 in the
complex, one with an entire methyl binding domain and the other with it lacking the
amino terminal half; these differences are apparently due to an alternative splice
acceptor site in the rrliddle of the DNA sequence for the MBD (17). Though Hendrich
and Bird found that "the shorter message makes up a significant portion of total Mbd3
message", Zhang et al. showed that "the major form" is the shorter version with the
truncated MBD (11,17). This accounts for why the MBD3 seems to lack specificity for
binding methylated DNA even though it has an MBD sequence. As a side note, though
the majority of the NuRD complex does not coassociate with MBD2, part of it does.
This addition of MBD2 creates a larger complex that shows specific interaction with
methylated DNA (18).

Though the last component of the NuRD complex originally described by Zhang
et al. is MTA2, recent information has shown that isoforms of MTA 1 and MTA3 can also
associate with the complex, possibly leading to functional differences between unique
forms of the complex (10,11,19). MTA2, so named because of its homology to MTA 1,
a metastasis associated protein, was originally shown to promote the activity of the
histone deacetylase components without the presence of either MBD3 or Mi2 to a level
comparable to that of the native complex (11). There has been considerable confusion
regarding the identity of the MTA family member in the complex until it was recently
postulated that there could be functional specialization based on the specific member
involved (10). To begin this, Tong et al. found that their version of the complex, NRD,
contained MTA1, not MTA2 (20). When Zhang et al. published the following year, they
discounted this based on the fact that the regions used to identify the family member
were shared between MTA 1 and MTA2 (11). Later, Fujita et al. showed that MTA3
could be a member of the NuRD in a manner dependent on the level of estrogen
present in the cell environment (21). These results provide an important link between
breast cancer and the MTA family of proteins. To further complicate matters, both
MTA 1 and MTA3 exist in alternatively spliced forms, present in different levels in cancer
cell lines of different types of tumors (10,21). In sum, there is growing evidence that the
particular MTA family member involved in the NuRD dictates functional specificity,
though this has not yet been conclusively shown. Additionally, the presence of a
metastasis-associated protein in the NuRD implicates it in having a role in cancer
processes.

ROLE OF CHD4
CHD4, also know
as

Mi-2~,

was found to

be the largest subunit in
the NuRD complex (13).
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Figure 2. Protein motifs in CHD4.

It was originally identified
as an autoantigen in dermatomyositis, an acquired muscle disease characterized by a
bluish-purple rash along with muscle weakness, often leading patients to have difficultly
sitting up or lifting things (22,23). Though Zhang et al. only reported finding CHD4 in
the NuRD, Tong et al. reported finding both CHD3 and CHD4, though the CHD4 in
greater amounts (13,20). CHD3 and CHD4 belong to a subfamily of the CHD proteins;
the domain structure is similar between the two, with the main difference being that the
CHD3 and CHD4 carboxy-terminal DNA binding doma.ins vary significantly (24). The
CHD proteins were so named because of their Chromodomain-Helicase-DNA-binding
domains (25). CHD4 is a 230-240 kD protein which has several domains including a
Nuclear Localization Signal, 2 PHD Zn-fingers, 2 chromodomains, a SWI2/SNF2-related
ATPase domain, and an additional carboxy terminal helicase (12,13,20). The nuclear
localization signal allows this protein to be guided back to the nucleus once it has been
translated in the cytoplasm; this is necessary because all of its roles are in the nucleus.
The PHD Zn-finger domains are formed of conserved cysteine residues that bind
to Zinc ions; it is postulated that CHD4 interacts with HDAC1 in the NuRD via the PHD
Zn-fingers (24). Chromodomains, named for their chromatin organization modifier
activity, are conserved protein folds that influence chromosome structure, leading to

changes in function. These domains are found in organisms from protists to mammals,
indicating strong evolutionary conservation (26). The SWI2/SNF2-related ATPase is a
DNA-dependent helicase (13). This activity indicates a role in nucleosome remodeling,
even leading to enzyme classification as nucleosome remodeling enzymes (6). Not
much research has been performed regarding the C-terminal helicase domain, but it
likely assists the SWI2/SNF2 helicase, though it could possibly be involved in DNA
damage repair pathways as well (27).
CHD4, the main component of the NuRD complex, contains ATPase activity
stimulated by histones and dependent on DNA (7). Wang et al. characterized the
biochemical activity of CHD4 outside of the NuRD, finding that recombinant CHD4 had
nucleosome remodeling activity comparable to the activity of the NuRD complex as a
whole. In their experiments, they found that both CHD4 and the NuRD complex
required the presence of nucleosomes rather than just naked DNA, indicating a role for
the histones (7). Additionally, Shimono et al. showed that the amino-terminal region of
CHD4 has a binding site for BRG1, the major component of the SWI/SNF complex, a
chromatin remodeling complex having known activation ability (28, 29). They also
found that the carboxy-terminal region of CHD4 binds RET finger protein (RFP),
increasing its repressive capability in a manner dependent on the amount of CHD4
present. Together, these results show that association of chromatin remodeling
proteins could lead to "supercomplexes" with the ability to effect epigenetic repression
through cooperation of methylation, deacetylation, and other methods of gene silencing
(28). In addition, von Zelewsky showed that the Mi-2 (CHD3 and CHD4) homologues in
C. e/egans played essential roles in development. Particularly, both homologues played

a role in the determination of vulval cell fate during development (30). As a result of
these studies, it is now known that CHD4 has roles outside of solely being the key
component of the NuRD complex (thought to be only repressive), including possible
roles during development and influences on transcriptional activation.

RELEVANCE TO CANCER
Though not yet shown to directly involve CHD4, chromatin remodeling has links
to human disease, notably cancer. It is signi'ficant that the MTA genes are part of the
NuRD complex because they were so named because of their correlation with
metastasis (31). Specifically, Toh et al. found that mRNA expression of mta1 was four
times as high in highly metastatic cell lines than in nonmetastatic cell lines. Additionally,
it is particularly notable that even in isogenic model organism populations, different
phenotypes are still evident. One possible cause for this is chromatin remodeling in
addition or in response to DNA methylation (32). Mutations in either the function or
targeting abilities of chromatin remodeling complexes usually have multi-system effects
or lead to cancer. This can be explained by loss of regulation by the particular complex
at multiple loci (32). One specific example of a chromatin remodeling enzyme related to
cancer is BRG1, a component of the SWI/SNF complex. It seems to act as a tumor
suppressor, an effect shown by its high mutation rate in a variety of cancer cell lines
(33). Perhaps even more interestingly, reintroduction of wild type BRG1 into cells
lacking BRG1 expression allowed the cells to revert from their transformed phenotype
and induce senescence (32,33). BRG1 also regulates cell cycle control through its
interactions with Rb and BRCA 1 (32 and references therein).

On a different, but related, note, global histone hypoacetylation has been shown
in gastrointestinal tumor cells and is correlated with increased tumor invasion and
metastasis (34). Histone deacetylase inhibitors such as Trichostatin A (TSA) induce
growth arrest and apoptosis in tumor cell lines, providing a possible treatment solution
for cancer with a great deal of potential. In conclusion, the chromatin structure inherent
to DNA storage can be modified to make the expression of some genes more or less
likely, and these modifications can have a vast influence on processes from cell cycle
regulation to chromosome stability, even to the point of aberrant regulation leading to
disease phenotypes such as cancer (35).

GENERATION OF MOUSE MODELS
Cells which had a genetrap inserted into the Chd4 gene were obtained from the
8aygenomics Embryonic Stem cell library. The location of the trap between exons 6
and 7 was confirmed by PCR analysis using the primers shown in Figure 3. Once
confirmed, the ES cells were used for blastocyst injections and the embryos were then
implanted into pseudo-pregnant females. The result of these efforts was the generation
of chimeric mice which were later mated with wild type mice to determine which of the
chimeras had germ line mutations in Chd4. Offspring were tested to ascertain their
genotype using the PCR analysis described in Figure 3 and heterozygous mice were
further bred to expand the colony.

...

Gene-trap primer

~-Geo

Gene trap

Chd 4 gene

\

...

Exon 6

Exon 7

Exon 8

CHD4 primer
En2: Engrailed 2 intron sequence
~-Geo: ~-gal-neomycin fusion gene

SA: Splice Acceptor site
SV40pA: SV40 poly A sequence

Figure 3. Schematic representation of the Chd4 disruption in ES cells.

RESULTS AND DISCUSSION
To systematically analyze the role

L

Lu K B

SMC

3m

of CHD4 and determine tissue specificity
in both young and old mice, we have
analyzed tissue specific expression
patterns using RT -PCR analysis with total
RNA isolated from different tissues. In
order to allow us to determine differential
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Figure 4. RT-PCR analysis of Chd4 expression. Total
RNA (5 J-lg) isolated from various tissues (L=liver,
H=heart, Lu=lung, K=lddney, B=brain, T=testis,
S=spleen, M =skeletal muscle) was reverse transcribed
and used in PCR reactions with primers specific for
Chd4 exons. C refers to control reaction using brain
RNA without reverse transcriptase.

expression, we used a 28 cycle PCR
reaction that allows semi-quantitative analysis. As shown in Figure 4, Chd4 is
expressed at different levels in a tissue specific manner in young and old mice. One
specific difference is that though three month old mice show expression in the liver,

heart, lung, kidney, brain, testes, and spleen, twenty-four month old mice show
expression in all of these except the lung. Additionally, there was conspicuous absence
of transcript from the skeletal muscle.

It remains to be seen what these differences

signify. This data also needs to be further confirmed with protein assays. After
procurement of an appropriate CHD4 antibody, we will check actual protein expression
levels in various tissues of both young and old mice to verify that different levels of
mRNA expression in the cells actually lead to different levels of protein production.
Since Chd4 homologues have been found to playa role in development in C.
e/egans (30), we decided to investigate possible roles and expression patterns for Chd4

in mouse embryos. We were able to do this because of the nature of the trap inserted
to disrupt the gene. Using X-gal and the promoter-less (3-galactosidase-neomycin
fusion construct, we were able to determine gene expression patterns in 10.5 days post
coitum mating of a heterozygotic male to a wild type female. As shown in Figure 5,
expression was evident in the brain precursors, the dorsal aorta, and dermal precursors.
Interestingly, the expression in the dermal precursors was significant enough to mask
the internal expression in the whole mount embryo (Figure 58). Upon slicing, though, it
became clear that there was not ubiquitous expression throughout the embryo, only in
the previously mentioned areas (Figure 5C).

This expression pattern indicates distinct,

tissue specific expression pointing to organ specific functions of CHD4. We plan to
examine embryonic expression data for Chd4 at 8.5,12.5, and 14.5 dpc to allow for a
more comprehensive perspective of its role in development.

A

c

Figure 5. Expression analysis of Chd4 in 10.5 d.p.c. embryos. Whole embryos were stained
with X-gal overnight to measure p-galactosidase activity and photographed. Panel A is a
control wild type embryo obtained from a Chd4 +/- cross to a wild type mouse. Please note that
the whole mounts of the controls was taken on a black background for visualization and
better contrast. Panel B is a stained whole mount embryo from a Chd4 heterozygous embryo,
while Panel C is a cross section obtained from the same heterozygous embryo.

Upon expansion of the colony and observation of the genotypes of the offspring
of heterozygous intercrosses, it became evident at first look that there were not any
pups nullizygous for Chd4. Though we have not yet had enough offspring for the data
to be statistically significant, the lack of any nullizygous offspring is at the least
conspicuous (expected and actual numbers of offspring are shown in Table 1). This
absence of nullizygous mice underlines the importance of CHD4 and its ability to affect
downstream targets. In addition to embryonic lethality showing that CHD4 is essential
for development, it would also show that there are no compensatory mechanisms that
can offset its absence. To further investigate this, we plan to continue expanding the
colony and determine the day and mechanism of embryonic lethality, if future results
confirm our preliminary data. Upon colony expansion, we will also investigate
organismal cancer susceptibility and relative life span.

Results of heterozygous intercrosses
Wild Type

Heterazyg au s

Null

Actual

4

21

0

Expected T

6

13

6

"'"based on a Mendelian distribution of the total nurrtJer of progeny

Table 1. Heterozygous intercross results. Genomic DNA samples
obtained from either tail clippings in the case of pups or
processing of the whole cell line in the case of MEF cell lines were
analyzed by peR to determine their genotype. These data
support our preliminary conclusion that Chd4 is necessary for
embryonic development.

Lastly, mouse embryonic fibroblasts (MEFs) were obtained from timed matings
between a heterozygous male and a wild type female. We characterized these cell
lines for growth kinetics and observed that the heterozygous line grew faster than did
the wild type (Figure 6). This enhanced growth rate gives us preliminary information
that CHD4 might be involved in cell growth suppression pathways, and its loss might
lead to cancerous phenotypes. In addition, it leads us to believe that CHD4 mutant
mice are likely to be more susceptible to organismal cancer growth. According to the
multi-step model of carcinogenesis, though, additional downstream mutations will be
necessary for a cancer phenotype to ensue. We eventually hope to obtain nullizygous
cell lines, even if the nullizygous pups display embryonic lethality. These cell lines will
enhance the growth curves and will also allow us to run microarray experiments to
determine which genes CHD4 affects downstream. In addition to the growth kinetic
experiments on the various cell lines, we will also do colony formation and DNA damage
repair assays.
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Figure 6. Chd4 Growth Curve. Cell lines heterozygous for Chd4 grow more rapidly than do their sibling wild
type counterparts. These experiments were conducted in duplicate on two heterozygous and two wild type cell
lines. Error bars represent standard error.

METHODS
For the RT -PCR experiment, total RNA was isolated from the indicated tissues
using Trizol reagent (Invitrogen) from 3 and 24 month old mice. Expression of Chd4
mRNA determined using reverse transcriptase PCR analysis followed by agarose gel
electrophoresis.
To determine the embryonic expression pattern, a wild type female was mated
with a male heterozygous for Chd4. The female was sacrificed at 10.5 dpc. The gene
trap inserted into the Chd4 gene (see Figure 3) contains a promoter-less

~-

galactosidase-neomycin fusion gene along with a splice acceptor site. This promoter-

less

~-galactosidase

gene allows visualization using X-gal staining in heterozygotic

embryos. It represents the expression pattern of CHD4 in the embryos due to its
presence after the splice acceptor site. When the gene is activated, the mRNA is made
normally until the location of the trap. The strong splice acceptor located in the trap
prevents alternative splicing with the appropriate exon and allows expression of the

~

galactosidase protein in the cells. Upon introduction of X-gal into the embryos, portions
of the embryo expressing

~-galactosidase

will turn the usually transparent X-gal blue,

allowing for differentiation between regions expressing

~-galactosidase

and those that

do not.
Mouse embryonic fibroblast (MEF) cell lines were obtained from a cross between
a male heterozygous for Chd4 and a wild type female. Briefly, 13.5 days post coitum
(dpc) embryos were harvested from pregnant females and disaggregated using a
syringe. The embryonic tissues were then plated onto 100 mm tissue culture plates and
passaged upon confluency. These cell lines were maintained at 37°C using humidified
air supplemented with 5% CO 2 in DMEM with 15% fetal bovine serum and Penstrep.
For the cell growth kinetic assays, 250,000 cells were plated on sterile 100 mm plates.
This was considered day O. The plates were counted on days 2,3,4,5, and 6 using a
Hemacytometer. Cell lines were labeled with nondescript names by a third party to
prevent any possible bias.
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